Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
COVID-19 Vaccine
Sort By
Newest First
Sign in
1 / 2
1 / 2
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07
Nov 09, 2023
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
lrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02
Apr 13, 2022
Column: Technology
mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-02
Mar 23, 2022
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-05
Mar 18, 2022
COVID-19 Vaccines
The Global Immunization Disparity
Komal Hatti
IPS-Integrated Project Services, LLC
PAO-02-022-CL-04
Mar 12, 2022
COVID-19 Vaccine
AGC Biologics Supports Omicron-Based Vaccine Candidate Manufacturing with Starting Material
AGC Biologics
PR-M02-22-07
Feb 09, 2022
COVID-19 Vaccine
FDA Approves SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine
Brand Institute
PR-M02-22-01
Feb 01, 2022
Thermal Packaging
With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine
Thermal Custom Packaging
PR-M01-22-02
Jan 04, 2022
Collaboration
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
IDT Biologika
PR-M12-21-02
Dec 15, 2021
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17
Nov 08, 2021
Gene Therapy
Pandemic Playbook for Gene Therapy Manufacturing
Ratish Krishnan; David Loong, Ph.D.; Nargisse El-Hajjami, Ph.D.
MilliporeSigma
PAO-09-21-CL-14
Sep 29, 2021
COVID-19 Vaccine
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
Novavax
PR-M06-21-028
Jun 22, 2021
Cleanrooms
Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned
Grant Merrill; Jose Jimenez
AES Clean Technology Inc.
PAO-06-21-CL-06
Jun 18, 2021
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-21-NI-01
Jun 04, 2021
COVID-19
Preparing for the Next Pandemic: Lessons Learned from COVID-19
Sheila Rocchio
eClinical Solutions
PAO-06-21-CL-01
Jun 01, 2021
COVID-19 Vaccine
Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo
Pfizer
PR-M05-21-014
May 20, 2021
COVID-19 Vaccine
Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial
Sanofi
PR-M05-21-011
May 17, 2021
Vaccines
A Look at Genetic Vaccine Development and Manufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-21-NI-03
May 17, 2021
COVID-19 Vaccines
The COVID-19 Vaccine Journey Continues
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-21-NI-02
May 13, 2021
Emergency Use
Pfizer and BioNtech Receive First U.S. Authorization for Emergency Use of Covid-19 Vaccine in Adolescents
Pfizer
PR-M05-21-007
May 11, 2021
